Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus: Using insulin glargine as basal insulin

被引：0
|
作者：
Kawamori, Ryuzo
Kadowaki, Takashi
Ishii, Hitoshi
Iwasaki, Manabu
Iwamoto, Yasuhiko
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A573 / A573
页数：1
相关论文
共 50 条
  • [21] Mechanisms and treatment of the "afternoon phenomenon" in patients with type 1 diabetes mellitus using glargine as basal insulin
    Rossetti, P
    Porcellati, F
    Fanelli, CG
    Bolli, GB
    DIABETES, 2005, 54 : A68 - A68
  • [22] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
    Jammah, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
  • [23] The efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
    Hadjiyianni, I.
    Asaro-Harris, A.
    Dahl, D.
    Lacaya, L. B.
    Pollom, R. K.
    Ilag, L. L.
    Zielonka, J. S.
    DIABETOLOGIA, 2015, 58 : S469 - S469
  • [24] Use of Insulin Glargine in Japanese Patients with Type 1 Diabetes
    Yamamoto-Honda, Ritsuko
    Takahashi, Yoshihiko
    Yoshida, Yoko
    Hara, Yoko
    Kawai, Atsuo
    Kitazato, Hiroji
    Tanaka, Takahisa
    Kajio, Hiroshi
    Kikuchi, Masatoshi
    Akanuma, Yasuo
    Noda, Mitsuhiko
    INTERNAL MEDICINE, 2007, 46 (13) : 937 - 943
  • [25] Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
    Hadjiyianni, I.
    Dahl, D.
    Lacaya, L. B.
    Pollom, R. K.
    Chang, C. L.
    Ilag, L. L.
    DIABETES OBESITY & METABOLISM, 2016, 18 (04): : 425 - 429
  • [26] COMPARISON OF INSULIN GLARGINE AND GLULISINE WITH INSULIN NPH AND REGULAR FOR GLYCEMIC CONTROL IN CHILDREN WITH TYPE -I DIABETES MELLITUS
    Hussain, Ibrar
    Soud-ul-Javed
    Abid, Ali Farhan
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (04): : 7972 - 7980
  • [27] Insulin glargine provides basal insulin requirements in the management of diabetes mellitus
    不详
    Drugs & Therapy Perspectives, 2002, 18 (7) : 7 - 9
  • [28] Insulin dose and weight profiles of pre- and post-meal insulin glulisine in a basal-bolus regimen with insulin glargine in patients with Type 1 diabetes
    Klaff, L
    Rosenstock, J
    Garg, S
    Souhami, E
    Ways, K
    DIABETOLOGIA, 2004, 47 : A300 - A300
  • [29] Pharmacokinetics and pharmacodynamics of insulin glargine-insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals
    Lamos, Elizabeth Mary
    Younk, Lisa M.
    Tate, Donna B.
    Davis, Stephen N.
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2016, 3 : 14 - 20
  • [30] Treatment satisfaction with insulin glargine and insulin glulisine in diabetes mellitus - Evaluated in an observational study in Germany
    Daikeler, R.
    Hoegy, B.
    Dippel, F. W.
    VALUE IN HEALTH, 2006, 9 (06) : A239 - A239
12345